Report error Found 60 Enz. Inhib. hit(s) with all data for entry = 12384
Affinity DataIC50: 4.5nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 5.30nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 5.90nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 6nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 6.40nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 6.60nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 7nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 7nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 7.60nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 7.60nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 8.20nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 8.5nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 9.5nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 9.80nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 10.5nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 11nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 12nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 17nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 22nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 28nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 31nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 33nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 36nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 40nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 42nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:Representative compounds of the present invention were assayed in vitro for CDK7 kinase-inhibitory activities using ADP-Glo platform. In detail, CDK7...More data for this Ligand-Target Pair
